EMEA-000461-PIP02-11-M04
Key facts
Invented name |
Cerdelga
|
Active substance |
Eliglustat (tartrate)
|
Therapeutic area |
Other
|
Decision number |
P/0385/2021
|
PIP number |
EMEA-000461-PIP02-11-M04
|
Pharmaceutical form(s) |
Capsule, hard
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Sanofi B.V.
E-mail: eumedinfo.GZ@sanofi.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|